DR. JOSEPH W. FAY, M.D.
Osteopathic Medicine at Worth St, Dallas, TX
License number
Texas G2698
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
Texas G2698
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
3410 Worth St SUITE 300, Dallas, TX 75246
Phone
(214) 370-1513
(214) 370-1585 (Fax)
(972) 997-8000
(972) 234-2987 (Fax)
(214) 370-1585 (Fax)
(972) 997-8000
(972) 234-2987 (Fax)
Personal information
See more information about JOSEPH W. FAY at radaris.comName
Address
Phone
307 W Silver Sands Dr, San Antonio, TX 78216
1175 Spring Mountain Dr, Canyon Lake, TX 78133
10313 Noel Dr, Frisco, TX 75035
Organization information
See more information about JOSEPH W. FAY at bizstanding.comNorth Texas Colon & Rectal - Joseph W Fay MD
3409 Worth St STE 600, Dallas, TX 75246
Categories:
Hematology Physicians & Surgeons
Phone:
(214) 820-2610 (Phone)
Professional information
Dr. Joseph W Fay, Dallas TX - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Blood & Marrow Transplant Svs
3410 Worth St SUITE 300, Dallas 75246
(214) 370-1500 (Phone)
Texas Oncology
3410 Worth St SUITE 3, Dallas 75246
(214) 370-1500 (Phone)
3410 Worth St SUITE 300, Dallas 75246
(214) 370-1500 (Phone)
Texas Oncology
3410 Worth St SUITE 3, Dallas 75246
(214) 370-1500 (Phone)
Certifications:
Hematology, 1978, Internal Medicine, 1975, Medical Oncology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Blood & Marrow Transplant Svs
3410 Worth St SUITE 300, Dallas 75246
Texas Oncology
3410 Worth St SUITE 3, Dallas 75246
Baylor University Medical Center at Dallas
3500 Gaston Ave, Dallas 75246
Medical City Dallas Hospital and Medical City Children’s Hospital
7777 Forest Lane Cir, Dallas 75230
3410 Worth St SUITE 300, Dallas 75246
Texas Oncology
3410 Worth St SUITE 3, Dallas 75246
Baylor University Medical Center at Dallas
3500 Gaston Ave, Dallas 75246
Medical City Dallas Hospital and Medical City Children’s Hospital
7777 Forest Lane Cir, Dallas 75230
Education:
Medical School
Ohio State University / College of Medicine
Graduated: 1972
Duke University Hospital
Natl Canc Inst
Ohio State University / College of Medicine
Graduated: 1972
Duke University Hospital
Natl Canc Inst
Method Of Treating Malignancies Through Induction Of Blood Immune Responses
US Patent:
2004008, May 6, 2004
Filed:
Nov 26, 2003
Appl. No.:
10/471119
Inventors:
Jacques Banchereau - Dallas TX, US
Anna Palucka - Dallas TX, US
Joseph Fay - Dallas TX, US
Ralph Steinman - Westport CT, US
Madhay Dhodapkar - New York NY, US
Knut Wittkowski - New York NY, US
Anna Palucka - Dallas TX, US
Joseph Fay - Dallas TX, US
Ralph Steinman - Westport CT, US
Madhay Dhodapkar - New York NY, US
Knut Wittkowski - New York NY, US
International Classification:
A61K048/00
US Classification:
514/044000
Abstract:
A method of treating malignancies through induction of immune responses has been found. In one aspect, the present invention is a method for treating malignancy comprising administering an effective amount of a vaccine comprising antigen-presenting cells loaded with at least two or more agents selected from the group consisting of tumor antigens and tumor antigen derived peptides. In another embodiment, the vaccine comprises at least two or more agents selected from the group consisting of tumor antigens and tumor antigen derived peptides which target antigen-presenting cells in the patient. The vaccines can also further comprise antigen-presenting cells loaded with control antigens used to determine the patient's immune competence. The evaluation of vaccine-induced immune responses in blood provides a predictive factor for treatment efficacy.
Joseph W Fay, Dallas TX
Specialties:
Hematologist
Address:
3409 Worth St, Dallas, TX 75246
3505 Gaston Ave, Dallas, TX 75246
3410 Worth St, Dallas, TX 75246
3505 Gaston Ave, Dallas, TX 75246
3410 Worth St, Dallas, TX 75246
Education:
Ohio State University, College of Medicine - Doctor of Medicine
College of Wooster - Bachelor of Arts (AB)
Duke University Hospital - Fellowship - Hematology
National Institutes of Health-Clinical Center - Residency - Oncology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine
College of Wooster - Bachelor of Arts (AB)
Duke University Hospital - Fellowship - Hematology
National Institutes of Health-Clinical Center - Residency - Oncology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Joseph Wayne Fay, Dallas TX
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology
Work:
Sammons Cancer Ctr At Baylor
3410 Worth St, Dallas, TX 75246 Baylor University Medical Center
3409 Worth St, Dallas, TX 75246 Texas Oncology
7777 Forest Ln, Dallas, TX 75230 Baylor University Medical Center
3500 Gaston Ave, Dallas, TX 75246
3410 Worth St, Dallas, TX 75246 Baylor University Medical Center
3409 Worth St, Dallas, TX 75246 Texas Oncology
7777 Forest Ln, Dallas, TX 75230 Baylor University Medical Center
3500 Gaston Ave, Dallas, TX 75246
Education:
The Ohio State University(1972)
Unique Transcriptional Signatures In The Blood Of Clinical Responders
US Patent:
2013018, Jul 18, 2013
Filed:
Sep 13, 2012
Appl. No.:
13/614400
Inventors:
Anna Karolina Palucka - Dallas TX, US
Jacques F. Banchereau - Montclair NJ, US
Joseph Fay - Dallas TX, US
Damien Chaussabel - Bainbridge Island WA, US
Jacques F. Banchereau - Montclair NJ, US
Joseph Fay - Dallas TX, US
Damien Chaussabel - Bainbridge Island WA, US
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
International Classification:
G06F 19/12
US Classification:
4242771, 506 9, 702 19
Abstract:
A method for using the blood transcriptional profile of patients with stage IV melanoma to generate networks associated with the possibility of prolonged survival and networks associated with clinical responses to dendritic cell (DC) vaccination as measured by tumor regression are disclosed herein.